Department of Internal Medicine

Division of Rheumatology

Articles, Patents and Intellectual Property

Clements PJ, Furst D, Wong W-K, Mayes M, White B, Wigley F, Weisman M, Barr W, Moreland L, Medsger Jr T, Steen V, Martin R, Collier D, Weinstein A, Lally E, Varga J, Weiner S, Andrews B, Abeles M, Seibold J.  High-dose vs low-dose D-penicillamine in early diffuse systemic sclerosis: Analysis of a two-year, double-blind, randomized, controlled clinical.  Arth Rheum 42:1194-1203, 1999.

Clements PJ, Wong W-K, Hurwitz EL, Furst DE, Mayes M, White B, Wigley F, Weisman M, Barr W, Moreland L, Medsger Jr. T, Steen V, Martin R, Collier D, Weinstein A, Lally E, Varga J, Weiner S, Andrews B, Abeles M, Seibold J.  Correlators of the disability index of the health assessment questionnaire: A measure of functional impairment in systemic sclerosis.  Arth Rheum 42:2372-2380, 1999.

Fernandez-Madrid F, VandeVord PJ, Yang X, KarvonenRL, Simpson PM,  Kraut MJ, Granda JL, Tomkiel JE.  Antinuclear antibodies as potential markers of lung cancer. Clin Cancer Res 5:1393-1400, 1999.

Freedman RR, Girgis RE, Mayes MD.  Endothelial and adrenergic dysfunction in Raynaud’s phenomenon and scleroderma.  J Rheum 26:2386-2388, 1999.

Freedman RR, Girgis RE Mayes MD.  Acute effect of nitric oxide on Raynaud’s phenomenon in scleroderma.  Lancet, 354:739, 1999 (letter).

Kirk TZ and Mayes MD.  IL-1 rescues scleroderma myofibroblast from serum-starvation induced cell death.  Biochem and Biophy Res Comm 255:129-132, 1999.

Lacey Jr JV, Garabrant DH, Laing TJ, Gillespie BW, Mayes MD, Cooper BC, Schottenfeld D.  Petroleum distillate solvents as risk factors for undifferentiated connective tissue disease (UCTD).  Am J Epidemiol, 149:761-770, 1999.

Mayes MD.  Epidemiologic studies of environmental agents and systemic autoimmune disease. Environ Health Perspectives 107:743-748, 1999.

Nelson DA, Koo WK. Interpretation of bone mass measurements in the growing skeleton. Calc Tiss Int; 65:1-3, 1999 (editorial).

Rao GN, Greger NG, Nelson DA. Whole body bone and body composition in a girl with achondroplasia, at ages 9 through 12.  J Clin Densitometry; 2: 185-190, 1999.

Whittum-Hudson JA, Gerard HC, Clayburne G, Schumacher HR, Hudson AP.  A non-invasive murine model of Chlamydia-induced reactive arthritis.  Revu de Rheumatisme (English), 66 (1 Suppl), 50S-56S, 1999.

Whittum-Hudson JA. Prevention vs. Treatment of chlamydial infections: A novel experimental approach. Invited article: Current treatment options in infectious disease 1:88-92, 1999.

Cheema MA, Rahman MU, Hudson AP, Whittum-Hudson, JA. Cervical chlamydia trachomatis in women at low risk for infection. Am J Med Sc, In press.

Fernandez-Madrid F, VandeVord PJ, Yang X, Karvonen RL, Simpson PM, Kraut MJ, Granda JL,  Tomkiel JE.  Antinuclear antibodies as potential markers of lung cancer. Clin Cancer Res, In Press.

Inman R, Whittum-Hudson JA, Schumacher HR, Hudson AP. Chlamydia and reactive arthritis, Invited review: Curr Opin Arthritis, In press.

Jabs DA, Lee B, Whittum-Hudson JA. Prendergast RA. Th1 vs Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice. Invest Ophthalmol Vis Sci In Press.

Nelson DA, Barondess DA. A noninvasive measure of physical maturity as a predictor of bone mass in children.  J Am Coll Nutr, In press.

Traboulsi EI, Whittum-Hudson JA, Mir S, Hussells IM.  Further association of defective fibrillin expression in patients with Marfan Syndrome and lens abnormalities. Ophthalmic Genet, In press.

Whittum-Hudson, JD, Ph.D. Submitted #10062-1, January 8, 1999 (provisional application 1/98); Treatment and diagnosis of AlzheimerÕs disease. Co-inventor

Books, Chapters and Reviews

GŽrard HC, Whittum-Hudson JA, Appelt DM, Balin BJ, Hudson AP. Chlamydia pneumoniae, APOE genotype, and alzheimer’s disease. Proceedings of RKI State-of-the-Art Workshop: Chlamydia pneumoniae and chronic diseases. Robert Koch Institute, Berlin, Germany. In press.

Abstracts, Letters to the Editor and Articles in Non-Refereed Journals

Aguilar MB, Cho  M, Reveille JD, Mayes MD, Arnett FC.  Prevalences of familial systemic sclerosis and other autoimmune diseases in three U.S. cohorts.  Arth Rheum (Suppl), S186, 1999.

GŽrard HC, Rudy D, Krausse-Opatz B, Zeidler H, Kohler L, Schumacher HR, Whittum-Hudson JA, Hudson AP. Expression of C trachomatis genes required for DNA synthesis/cell division in active vs persistent infection. (Platform presentation by HCG), Arth Rheum (Suppl), S384, 1999.

GŽrard HC, Lu L, Schumacher HR, Clayburne G, Whittum-Hudson JA, Rank RG, Hudson AP. Time course and pathologic consequences of dissemination of Chlamydia to the joint following genital infection in a guinea pig model of reactive arthritis (ReA). Am Soc Micro Abstracts #B\D123, 1999. (poster)

Guice D, Lumley M, Gillis M, Mosley-Williams A, and Leisen J.  Significant others as informants of adherence and health status in patients with systemic lupus erythematosus.  Psychosomatic Med 61:90, 1999.

Hudson AP, Rudy D, Krausse-Opatz B, Zeidler H, Kohler L, Schumacher HR, Whittum-Hudson JA, Gerard HC.  Energy metabolism of C trachomatis during active vs persistent infection. (Poster presentation) Arth Rheum (Suppl), S336, 1999.

Jabs DA, Lee B, Whittum-Hudson JA, Prendergast RA. TH1 vs TH2 immune responses in autoimmune lacrimal gland disease in MRL/MP mice. Arth Rheum (Suppl), S138, 1999. (poster)

Jabs DA, Lee B, Whittum-Hudson JA, Prendergast RA. TH1 vs TH2 immune responses in autoimmune lacrimal gland disease in MRL/MP mice.  Invest Ophthalmol Vis Sci 40 (4 Suppl), S553, 1999. (poster)

Nelson DA, Barondess DA, Hendrix SL, Singh M. Ethnic comparison of radiographicmeasurements and the Singh Index in the proximal femur of postmenopausal women. J Bone Min Res,14 (1 Suppl), S503, 1999.

Whittum-Hudson JA, Gerard HC, Davis E, Vora G, Saltzman WM, Stuart ES, Schumacher HR, Hudson AP. Immunomodulation of experimental chlamydia-associated reactive arthritis. (Invited as a plenary session talk) Arth Rheum (Suppl), S400, 1999.

Rorer EM, Whittum-Hudson JA, Jabs DA, Prendergast RA. Relative transcript levels of cytokines in autoimmune dacryoadenitis in MRL/MP-lpr/lpr mice.  Invest Ophthalmol Vis Sci 40 (4 Suppl), S553, 1999.  (poster)

Whittum-Hudson JA, Davis E, Vora G, Kuo P, Hudson AP, Schumacher HR, Saltzman WR, Stuart ES. Effects of chlamydial exoglycolipid-specific anti-idiotypic antibody vaccine on murine genital chlamydial infection. (poster), Am Soc Micro Abstracts 85, 1999.

Whittum-Hudson JA, Davis E, Vora G, Kuo P, Hudson A, Schumacher HR, Saltzman WM, Stuart ES. The chlamydial anti-idiotypic antibody vaccine: tests in allogeneic mice after genital infection. Meeting  (poster and workshop oral presentation), Immunol Lett 69: 97, 1999.

Whittum-Hudson J, Davis E, Vora G, Kuo P, Schumacher HR, Stuart ES, Saltzman WM. Oral anti-idiotypic antibody to Chlamydial GLXA reduces genital infection and dissemination to joints. (Oral presentation and poster)  FASEB J 13, A288, 1999.

Back to Internal Medicine